Functional disorders in non-culprit coronary arteries and their implications in patients with acute myocardial

Felipe Díez-Delhoyo1, Enrique Gutiérrez-Ibañes2, Francisco Fernández-Avilés3

  • 1Department of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañon, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.

Insights

Multivessel disease in ST-elevation myocardial infarction presents challenges due to non-culprit artery physiology. This review explores microcirculation, endothelium, revascularization strategies, and assessment indices for better patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Physiology
  • Interventional Cardiology

Background:

  • Multivessel disease affects 30-50% of ST-elevation acute myocardial infarction patients.
  • Non-culprit artery plaques, though seemingly stable, frequently cause adverse cardiovascular events.
  • Microvascular and endothelial dysfunction in non-culprit arteries impact prognosis and stenosis assessment.

Purpose of the Study:

  • To review methods for studying microcirculation in non-culprit arteries.
  • To discuss the role of endothelium and microvascular function in non-culprit arteries.
  • To evaluate revascularization strategies, limitations of hyperemic indices, and potential of resting indices.

Main Methods:

  • Literature review focusing on microcirculation, endothelial function, and physiological indices.
  • Analysis of current evidence on non-culprit artery physiology and management.
  • Discussion of advanced assessment techniques and their clinical implications.

Main Results:

  • Non-culprit artery physiology is complex and impacts patient outcomes.
  • Microvascular and endothelial dysfunction are significant factors in acute myocardial infarction.
  • Current physiological indices have limitations in assessing non-culprit artery stenosis severity.

Conclusions:

  • Complete revascularization strategies should be based on proven ischemia.
  • Novel resting-indices may offer better assessment in acute settings.
  • Further research is needed to optimize management of non-culprit artery disease.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
367
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
844
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
379
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
225